Clinical Trials on Malignant Melanoma in United Kingdom
Total 4393 results
-
Immodulon Therapeutics LtdTerminatedMalignant MelanomaUnited Kingdom
-
National Cancer Institute (NCI)TerminatedRecurrent Melanoma | Stage IV Melanoma | Acral Lentiginous Malignant Melanoma | Lentigo Maligna Malignant Melanoma | Nodular Malignant Melanoma | Solar Radiation-related Skin Melanoma | Superficial Spreading Malignant MelanomaUnited States
-
Royal Marsden NHS Foundation TrustUnknown
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation TrustCompletedA Trial Looking at Nilotinib to Treat Acral and Mucosal Melanoma Skin Cancer That Has Spread (NICAM)Mucosal Lentiginous Melanoma | Acral Lentiginous Malignant MelanomaUnited Kingdom
-
Scancell LtdRecruitingMelanoma (Skin) | Malignant Melanoma | Melanoma Stage IV | Melanoma Stage IIIUnited Kingdom
-
Immunocore LtdTerminated
-
Scancell LtdTerminated
-
AstraZenecaCompletedMelanoma | Malignant MelanomaUnited Kingdom, Netherlands
-
Skin Analytics LimitedCompleted
-
The Christie NHS Foundation TrustCancer Research UK; Christie Charitable FundsCompleted
-
Immunocore LtdCompletedMalignant MelanomaUnited Kingdom, United States
-
Lynn E. Spitler, MDGenentech, Inc.; Celgene CorporationCompletedMetastatic Malignant MelanomaUnited States
-
Bristol-Myers SquibbMedarexCompletedMalignant MelanomaUnited States, Peru, Canada, Israel, Italy, United Kingdom
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsUnited States, South Africa, Croatia, Brazil, Egypt
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsKorea, Republic of, Brazil, United States, Canada, Cyprus
-
Baylor Research InstituteNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedMalignant Melanoma Stage III | Malignant Melanoma Stage IVUnited States
-
Eli Lilly and CompanyCompletedMetastatic Malignant MelanomaUnited States
-
Antisoma ResearchCompletedMetastatic Renal Cell Carcinoma | Metastatic Malignant MelanomaUnited Kingdom, New Zealand
-
Bristol-Myers SquibbCompletedUnresectable Stage III or IV Malignant MelanomaUnited States, Peru, Norway, Italy, Sweden, Denmark, Israel
-
Piramal Enterprises LimitedMelanoma Research Foundation Breakthrough ConsortiumSuspendedAdvanced or Inoperable Malignant Melanoma With BRAF MutationUnited States
-
National Cancer Institute (NCI)CompletedMelanoma | Malignant Melanoma | Melanoma, Experimental | Experimental MelanomasUnited States
-
MorphotekTerminatedMelanoma | Metastatic Melanoma | Advanced Melanoma | Malignant Metastatic MelanomaUnited States
-
University of California, IrvinePfizerCompletedMelanoma | Malignant Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC MelanomaUnited States
-
Hoffmann-La RocheTerminatedMalignant MelanomaUnited States, France, Australia, United Kingdom, Italy, Spain, Germany, Israel, Poland, Slovakia
-
Leap Therapeutics, Inc.Cancer Research Institute, New York CityCompletedUnresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor MalignanciesUnited States
-
Bristol-Myers SquibbTerminatedMalignant MelanomaGermany, United States, Mexico, Denmark, France, Belgium, United Kingdom, Spain
-
National Cancer Institute (NCI)TerminatedMelanoma | Malignant Melanoma | Melanoma, ExperimentalUnited States
-
Massachusetts General HospitalDana-Farber Cancer InstituteRecruiting
-
ImmVira Pharma Co. LtdSuspendedMelanoma | Malignant MelanomaUnited States
-
American Regent, Inc.CompletedMalignant MelanomaUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteCompletedMalignant MelanomaUnited States
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalCompletedMelanoma | Malignant MelanomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBioNumerik Pharmaceuticals, Inc.Terminated
-
MedImmune LLCCompletedMalignant MelanomaUnited States
-
University of Colorado, DenverNational Comprehensive Cancer Network; Taiho Oncology, Inc.RecruitingMalignant MelanomaUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteCompletedMalignant MelanomaUnited States
-
Ludwig Institute for Cancer ResearchCancer Research Institute (CRI)CompletedMalignant MelanomaUnited States
-
CelgenePrologue Research InternationalCompleted
-
Milton S. Hershey Medical CenterCompletedMalignant MelanomaUnited States
-
University of ArizonaTerminatedMalignant MelanomaUnited States
-
University of California, DavisCompletedMelanoma | Malignant MelanomaUnited States
-
University of Kansas Medical CenterCompletedMalignant MelanomaUnited States
-
Oxford University Hospitals NHS TrustUniversity of Oxford; Barts & The London NHS Trust; Ninewells HospitalCompletedMelanoma Stage III | Melanoma, Stage II | Melanoma, Stage IUnited Kingdom
-
Eli Lilly and CompanyCompletedMalignant MelanomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedMalignant MelanomaUnited States
-
CelgeneNYU Langone Health; Syneos Health; Celerion; ApoCell, Inc.CompletedMalignant MelanomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNational Gene Vector LaboratoryCompletedMalignant MelanomaUnited States
-
James Graham Brown Cancer CenterUniversity of LouisvilleCompleted
-
Astellas Pharma IncOSI Pharmaceuticals; Cell PathwaysTerminated
-
Eli Lilly and CompanyMemorial Sloan Kettering Cancer CenterCompleted